PD L1 News and Research

RSS
Stem cell transplant following treatment with PD-1 inhibitor is safe, effective for patients with Hodgkin lymphoma

Stem cell transplant following treatment with PD-1 inhibitor is safe, effective for patients with Hodgkin lymphoma

New screening method can rapidly discover potential cancer-treating compounds

New screening method can rapidly discover potential cancer-treating compounds

Study: TBK1 protein promotes cancer development, suppresses immune response to the disease

Study: TBK1 protein promotes cancer development, suppresses immune response to the disease

Study suggests two new approaches against bone metastases from prostate cancer

Study suggests two new approaches against bone metastases from prostate cancer

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Combination therapy improves survival in patients with hepatocellular carcinoma

Combination therapy improves survival in patients with hepatocellular carcinoma

Promising method to identify aggressive breast cancers that will respond to immunotherapy

Promising method to identify aggressive breast cancers that will respond to immunotherapy

NCCN ORP plans to support phase II randomized trial for lung cancer patients

NCCN ORP plans to support phase II randomized trial for lung cancer patients

Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

Creatine serves as a molecular battery to power killer T cells' fight against cancer

Creatine serves as a molecular battery to power killer T cells' fight against cancer

Study: High levels of circ E7 is a positive prognostic marker in anal squamous cell carcinoma

Study: High levels of circ E7 is a positive prognostic marker in anal squamous cell carcinoma

New protein painting technology could transform drug discovery process

New protein painting technology could transform drug discovery process

Novel immunotherapy combination could provide fresh hope for patients with cervical cancer

Novel immunotherapy combination could provide fresh hope for patients with cervical cancer

Higher levels of genetic mutations linked to improved outcomes in lung cancer patients

Higher levels of genetic mutations linked to improved outcomes in lung cancer patients

Oncologists respond quickly to emerging FDA safety data for drugs, study finds

Oncologists respond quickly to emerging FDA safety data for drugs, study finds

Pembrolizumab provides added benefit for subpopulations of patients with metastatic NSCLC

Pembrolizumab provides added benefit for subpopulations of patients with metastatic NSCLC

Mutations linked with sensitivity or resistance to immunotherapy in mNSCLC

Mutations linked with sensitivity or resistance to immunotherapy in mNSCLC

Age affects efficacy of immunotherapy treatment for breast cancer, preclinical study reveals

Age affects efficacy of immunotherapy treatment for breast cancer, preclinical study reveals

Genetically altering protein in colon cancer cells may enhance efficacy of chemotherapy

Genetically altering protein in colon cancer cells may enhance efficacy of chemotherapy

Researchers develop new gene editing system that could be used for anticancer immunotherapy

Researchers develop new gene editing system that could be used for anticancer immunotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.